117 related articles for article (PubMed ID: 19716825)
1. Inhibition of farnesylpyrophosphate synthase prevents angiotensin II-induced hypertrophic responses in rat neonatal cardiomyocytes: involvement of the RhoA/Rho kinase pathway.
Ye Y; Hu SJ; Li L
FEBS Lett; 2009 Sep; 583(18):2997-3003. PubMed ID: 19716825
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a RhoA-ROCK-dependent pathway.
Hunter JC; Zeidan A; Javadov S; Kilić A; Rajapurohitam V; Karmazyn M
J Mol Cell Cardiol; 2009 Dec; 47(6):810-8. PubMed ID: 19799911
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy.
Ye Y; Mou Y; Bai B; Li L; Chen GP; Hu SJ
Int J Biochem Cell Biol; 2010 Dec; 42(12):2056-64. PubMed ID: 20884373
[TBL] [Abstract][Full Text] [Related]
4. Alendronate prevents angiotensin II-induced collagen I production through geranylgeranylation-dependent RhoA/Rho kinase activation in cardiac fibroblasts.
Ye Y; Lv X; Wang MH; Zhu J; Chen SQ; Jiang CY; Fu GS
J Pharmacol Sci; 2015 Dec; 129(4):205-9. PubMed ID: 26627555
[TBL] [Abstract][Full Text] [Related]
5. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
Wen Y; Zhang XJ; Ma YX; Xu XJ; Hong LF; Lu ZH
Scand J Clin Lab Invest; 2009; 69(4):518-25. PubMed ID: 19347742
[TBL] [Abstract][Full Text] [Related]
7. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N
Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
Yang J; Zhu HH; Chen GP; Ye Y; Zhao CZ; Mou Y; Hu SJ
Int J Biochem Cell Biol; 2013 Mar; 45(3):657-66. PubMed ID: 23277274
[TBL] [Abstract][Full Text] [Related]
9. Ginseng (Panax quinquefolius) attenuates leptin-induced cardiac hypertrophy through inhibition of p115Rho guanine nucleotide exchange factor-RhoA/Rho-associated, coiled-coil containing protein kinase-dependent mitogen-activated protein kinase pathway activation.
Moey M; Rajapurohitam V; Zeidan A; Karmazyn M
J Pharmacol Exp Ther; 2011 Dec; 339(3):746-56. PubMed ID: 21875949
[TBL] [Abstract][Full Text] [Related]
10. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation.
Guilluy C; Rolli-Derkinderen M; Loufrani L; Bourgé A; Henrion D; Sabourin L; Loirand G; Pacaud P
Circ Res; 2008 May; 102(10):1265-74. PubMed ID: 18420945
[TBL] [Abstract][Full Text] [Related]
11. Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei.
Zeidan A; Javadov S; Chakrabarti S; Karmazyn M
Cardiovasc Res; 2008 Jan; 77(1):64-72. PubMed ID: 18006472
[TBL] [Abstract][Full Text] [Related]
12. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats.
Soliman H; Craig GP; Nagareddy P; Yuen VG; Lin G; Kumar U; McNeill JH; Macleod KM
Cardiovasc Res; 2008 Jul; 79(2):322-30. PubMed ID: 18411229
[TBL] [Abstract][Full Text] [Related]
13. Propofol depresses angiotensin II-induced cardiomyocyte hypertrophy in vitro.
Zou XJ; Yang L; Yao SL
Exp Biol Med (Maywood); 2008 Feb; 233(2):200-8. PubMed ID: 18222975
[TBL] [Abstract][Full Text] [Related]
14. Prevention of RhoA activation and cofilin-mediated actin polymerization mediates the antihypertrophic effect of adenosine receptor agonists in angiotensin II- and endothelin-1-treated cardiomyocytes.
Zeidan A; Gan XT; Thomas A; Karmazyn M
Mol Cell Biochem; 2014 Jan; 385(1-2):239-48. PubMed ID: 24096734
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ADP-ribosyl cyclase attenuates angiotensin II-induced cardiac hypertrophy.
Gul R; Park JH; Kim SY; Jang KY; Chae JK; Ko JK; Kim UH
Cardiovasc Res; 2009 Feb; 81(3):582-91. PubMed ID: 18719074
[TBL] [Abstract][Full Text] [Related]
17. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
Li M; Li Z; Sun X
Eur J Pharmacol; 2008 Sep; 591(1-3):219-23. PubMed ID: 18619957
[TBL] [Abstract][Full Text] [Related]
18. [Molecular mechanism of nitric oxide in preventing cardiomyocytes from hypertrophic response induced by angiotensin II].
Liu PQ; Lu W; Pan JY
Sheng Li Xue Bao; 2002 Jun; 54(3):213-8. PubMed ID: 12075467
[TBL] [Abstract][Full Text] [Related]
19. Crucial Role of ROCK2-Mediated Phosphorylation and Upregulation of FHOD3 in the Pathogenesis of Angiotensin II-Induced Cardiac Hypertrophy.
Zhou Q; Wei SS; Wang H; Wang Q; Li W; Li G; Hou JW; Chen XM; Chen J; Xu WP; Li YG; Wang YP
Hypertension; 2017 Jun; 69(6):1070-1083. PubMed ID: 28438902
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation.
Aoki H; Izumo S; Sadoshima J
Circ Res; 1998 Apr; 82(6):666-76. PubMed ID: 9546375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
